Antibodies In-Depth Focus 2017

Posted: 15 March 2017 | | No comments yet

Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy…

digital issue #1 2017 in-depth focus antibodies

Included in this Antibodies In-Depth Focus:

  • Developability assessment of therapeutic antibodies
    Lone Friis and David Matthews – MRC Technology Centre for Therapeutics Discovery
  • Antibody-based immunooncology: hopes and perils
    Ismael Samudio, The Centre for Drug Research and Development (CDRD) and Gregorio Aversa, Immcure Theraputics

This Antibodies In-Depth Focus is restricted to logged-in members. Login or subscribe free to read it.

Send this to a friend